doi: 10.1016/0028-3908(64)90006-1.
EFFECT OF SOME BENZYLHYDRAZINES AND BENZYLOXYAMINES ON DOPA AND 5-HYDROXYTRYPTOPHAN DECARBOXYLASE IN VIVO
- PMID: 14336525
- DOI: 10.1016/0028-3908(64)90006-1
Item in Clipboard
EFFECT OF SOME BENZYLHYDRAZINES AND BENZYLOXYAMINES ON DOPA AND 5-HYDROXYTRYPTOPHAN DECARBOXYLASE IN VIVO
Int J Neuropharmacol.
1964 May.
No abstract available
Similar articles
-
A SENSITIVE ASSAY FOR 5-HYDROXYTRYPTOPHAN DECARBOXYLASE.Biochem Pharmacol. 1964 May;13:805-6. doi: 10.1016/0006-2952(64)90021-8. Biochem Pharmacol. 1964. PMID: 14181286 No abstract available.
-
5-HYDROXYTRYPTOPHAN DECARBOXYLASE IN RAT BRAIN: EFFECT OF HYPOTHALAMIC LESIONS.Science. 1965 Feb 19;147(3660):887-8. doi: 10.1126/science.147.3660.887. Science. 1965. PMID: 14245772
-
CEREBRAL METABOLISM OF DOPA-C14 IN RATS.Int J Neuropharmacol. 1964 Apr;3:37-43. doi: 10.1016/0028-3908(64)90043-7. Int J Neuropharmacol. 1964. PMID: 14334595 No abstract available.
-
METABOLISM OF TRYPTAMINE AND RELATED COMPOUNDS IN THE CENTRAL NERVOUS SYSTEM.Br Med Bull. 1965 Jan;21:62-5. doi: 10.1093/oxfordjournals.bmb.a070358. Br Med Bull. 1965. PMID: 14292502 Review. No abstract available.
-
Aromatic L-amino acid decarboxylases: mechanistic features and microbial applications.Appl Microbiol Biotechnol. 2022 Jun;106(12):4445-4458. doi: 10.1007/s00253-022-12028-4. Epub 2022 Jun 28. Appl Microbiol Biotechnol. 2022. PMID: 35763068 Review.
Cited by
-
Brocresine in Parkinson's disease. Action of a peripheral and central decarboxylase inhibitor in potentiating levodopa.J Neurol Neurosurg Psychiatry. 1973 Feb;36(1):27-9. doi: 10.1136/jnnp.36.1.27. J Neurol Neurosurg Psychiatry. 1973. PMID: 4570903 Free PMC article. Clinical Trial.
-
NSD 1034: an amino acid decarboxylase inhibitor with a stimulatory action on dopamine synthesis not mediated by classical dopamine receptors.Naunyn Schmiedebergs Arch Pharmacol. 1988 Aug;338(2):148-61. doi: 10.1007/BF00174863. Naunyn Schmiedebergs Arch Pharmacol. 1988. PMID: 3141816
-
Inhibition of tyrosine degradation in vivo by the dopa decarboxylase blocking agent NSD-1034.Experientia. 1968 May 15;24(5):429-30. doi: 10.1007/BF02144368. Experientia. 1968. PMID: 5674965 No abstract available.
-
Monoamine oxidase inhibitors antagonize the acceleration of brain dopamine synthesis induced by neuroleptic drugs in vivo: implications for the treatment of Tardive dyskinesia.Experientia. 1975 Jun 15;31(6):669-71. doi: 10.1007/BF01944619. Experientia. 1975. PMID: 237777 No abstract available.
-
A pharmacological study of the adrenergic mechanisms involved in the stretch reflex of the decerebrate rat.Br J Pharmacol. 1974 Mar;50(3):365-74. doi: 10.1111/j.1476-5381.1974.tb09611.x. Br J Pharmacol. 1974. PMID: 4850262 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Miscellaneous